U.S. markets closed

Gerresheimer AG (GRRMF)

Other OTC - Other OTC Delayed Price. Currency in USD
111.80+14.76 (+15.21%)
At close: 09:30AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close97.04
BidN/A x N/A
AskN/A x N/A
Day's Range111.80 - 114.25
52 Week Range91.00 - 114.25
Avg. Volume564
Market Cap3.862B
Beta (5Y Monthly)0.92
PE Ratio (TTM)31.40
EPS (TTM)3.56
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for GRRMF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: ConvaTec Group PLCOriginally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and continence care are the largest divisions, accounting for 30% and 26% of total revenue, respectively. Ostomy contributes 25% of revenue and infusion sets 19%.
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more